Mammography Market – High Prevalence of Breast Cancer Patients Worldwide is Expected to Lead the Market Growth – Growing at a Compound Annual Growth Rate (CAGR) 10.1% from 2022 to 2028
As stated in our extensive report; the Global Mammography Market accounted for USD 1.8 Billion in 2021.
Mammography is the procedure of using a low-dose x-ray system for examining the human breast for diagnosis and screening. In addition, the primary function of Mammography is the early detection of breast cancer, usually with the detection of distinctive masses or microcalcifications. The procedure is safe, with only a small amount of radiation exposure, and proves to help reduce related death.
In developing regions, breast cancer is the mainly common type of malignancy with high growth in the cases of breast cancer patients in women. Moreover, the developments in Mammography techniques gradually reduce breast cancer deaths. In addition, the increase in investment from several organizations in breast cancer screening campaigns and the advancements in technologies in breast imaging are other vital factors that are expected to propel the growth of the Mammography Market during the forecast period. Furthermore, supportive government policies and initiatives across the globe to create awareness among the female population concerning breast cancer and its symptoms will drive global market development.
Furthermore, healthcare organizations are undertaking several screening programs to reduce cancer mortality rates across the globe. For example, healthcare organizations such as the National Cancer Institute, the National Comprehensive Cancer Network, and American Medical Association recommend routine mammograms for women over 40 years of age to advance cancer screening participation to avoid developing breast cancer.
North America holds the largest market share in the Mammography Market and is projected to continue this development in the forecast period. The growing occurrence of breast cancer cases and the rise in awareness regarding the early diagnosis of breast cancer drive the market growth in this region. In addition, in the U.S., about 1 in 8 women (roughly 13%) can develop invasive breast cancer. Therefore, the expanding number of Mammography tests executed will undoubtedly impact the U.S. market, fuelling regional market growth. Moreover, the product launchings by leading companies and the growing implementation of superior Mammography devices with innovative technologies will support the market growth in this region.
Some of the key players in the Global Mammography Market include- Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips NV, PLANMED OY and others.